期刊文献+

血管活性肠肽对前列腺癌DU145细胞迁移侵袭及上皮-间充质转化的影响

Effect of vasoactive intestinal peptide on cell migration and invasion and epithelial - mesenchymal transition in prostate cancer DU145 cells
原文传递
导出
摘要 目的观察血管活性肠肽(VIP)对前列腺癌(DU145)细胞迁移、侵袭的影响并探讨其在上皮-间充质转化(EMT)过程中机制。方法用浓度分别为0、25、50、100μmol/L的VIP处理DU145细胞,采用反转录聚合酶链反应(RT-PCR)和Westernblot检测24h时DU145细胞中E-钙黏蛋白(E—cadherin)、波形蛋白(Vimentin)、SnailmRNA和蛋白的表达;采用划痕实验和Transwell迁移、侵袭实验检测48h时DU145细胞运动、迁移、侵袭能力变化。结果随着VIP浓度的增加,在24h时,细胞中E—cadherin、Vimentin、SnailmRNA表达增加(0.897±0.053、0.715±0.041、0.521±0.036、0.343±0.029;0.586±0.061、0.827±0.089、1.329±0.107、1.764±0.135;0.645±0.055、0.917±0.074、1.383±0.097、1.725±0.124),差异有统计学意义(P〈0.05);在48h,划痕实验显示DU145运动能力逐渐增加,Transwell迁移、侵袭实验显示穿越小室的细胞个数也增多[(76.7±5.8)、(104.5±6.7)、(128.34-10.4)、(147.7±12.6)个;(84.2±6.4)、(118.3±10.3)、(142.1±13.7)、(173.6±15.4)个],差异均有统计学意义(P〈0.05)。结论VIP可通过EMT促使前列腺癌DU145细胞运动、迁移及侵袭能力增加。 Objective To observe the effect of intestinal peptide on cell migration and invasion of the DU145 cells, and explore the mechanism of epithelial - mesenchymal transition. Methods DUI45 cells were treated with VIP at concentrations of 0, 25, 50 and 100 μmol/L, respectively. E -cadherin, Vimentin, and Snail mRNA and protein were detected by reverse transcriptase -polymerase chain reaction ( RT - PCR) and Western blotting respectively at 24 h. The cell mobility, migration and invasion ability of DU145 cells were respectively measured by wound - healing assay, Transwell migration and invasion assays at 48 h. Results With the increases of concentrations of VIP for 24 h, the expression levels of E - cadher- in, Vimentin, and Snail mRNA in PC -3 cells were increased at 24 h (0. 897 ±0. 053, 0. 715 ±0. 041, 0.521±0.036, 0.343 ±0.029; 0.586 ±0.061, 0.827 ±0.089, 1.329 ±0.107, 1.764 ±0.135; 0. 645 ±0. 055, 0. 917 ±0. 074, 1. 383 ±0. 097, 1. 725 ±0. 124;P 〈0. 05). Meanwhile, the cell mobility was increased, the number of migrative cells and invasive cells was significantly increased gradually with the increased concentrations of VIP [ (76.7 ± 5.8 ), ( 104. 5 ± 6. 7 ), ( 128.3 ± 10.4 ), ( 147.7 ± 12. 6 ) cells; (84. 2 ±6.4), ( 118.3 ± 10. 3), ( 142. 1 ± 13.7), ( 173.6 ± 15.4) eells;P 〈0. 01 ]. Conclusion VIP can increase ability of movement, migration and invasion of prostate cancer DU145 cells by epithelial - mesenchymal transition.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2016年第6期1504-1506,共3页 Chinese Journal of Experimental Surgery
基金 青岛市公共领域科技支撑计划资助项目(10-3-34-11-nsh)
关键词 血管活性肠肽 前列腺癌 肿瘤转移 上皮-间充质转化 Vasoactive intestinal peptide Prostate carcinoma Tumor metastasis Epithelial - mesenehymal transition
  • 相关文献

参考文献2

二级参考文献22

  • 1Schally AV,Comaru-Schally AM,Plonowski A,et al.Peptide analogs in the therapy of prostate cancer[J].Prostate,2000,45 (2):158-166.
  • 2Komuro H,Kaneko S,Kaneko M,et al.Expression of angiogenic factors and tumor progression in human neuroblastoma[J].J Cancer Res Clin Oncol,2001,127 (12):739-743.
  • 3Weidner N.Intratumor microvessel density as a prognostic factor in cancer[J].Am J Pathol,1995,147 (1):9-19.
  • 4Wilder RL.Neuroimmunoendocrinology of the rheumatic diseases:past,present,and future[J].Ann N Y Acad Sci,2002,966:13-19.
  • 5Fernández-Martínez AB,Bajo AM,Isabel Arenas M,et al.Vasoactive intestinal peptide (VIP) induces malignant transformation of the human prostate epithelial cell line RWPE-1[J].Cancer Lett,2010,299 (1):11-21.
  • 6Fernández-Martínez AB,Bajo AM,Sánchez-Chapado M,et al.Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells[J].Prostate,2009,69 (7):774-786.
  • 7Xie Y,Wolff DW,Lin MF,et al.Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells[J].Mol Pharmacol,2007,72(1):73-85.
  • 8Gutiérrez-Ca(n)as I,Rodrígnez-Henche N,Bola(n)os O,et al.VIP and PACAP are autocrine factors that protect the androgen-independent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawal[J].Br J Pharmacol,2003,139 (5):1050-1058.
  • 9Moody TW,Hill JM,Jensen RT.VIP as atrophic factor in the CNS and cancer cells[J].Peptides,2003,24(1):163-177.
  • 10Carmeliet P,Jain RK.Angiogenesis in cancer and other diseases[J].Nature,2000,407 (6801):249-257.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部